ACCESSION: MSBNK-SMB_Measured-HSA015P0256001
RECORD_TITLE: Annotated; Palmitic amide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 27
COMMENT: RAW_SPEC {'EL21_pos_2332': {'bp': 77506.0, 'sum': 267578.0}, 'EL12_pos_1966': {'bp': 75236.0, 'sum': 253575.0}, 'EL12_pos_2333': {'bp': 71380.0, 'sum': 250644.0}, 'EL20_pos_1877': {'bp': 70498.0, 'sum': 203258.0}, 'EL07_pos_2429': {'bp': 69070.0, 'sum': 188594.0}, 'EL11_pos_1895': {'bp': 67776.0, 'sum': 203627.0}, 'EL07_pos_1763': {'bp': 66893.0, 'sum': 164812.0}, 'EL06_pos_2284': {'bp': 66301.0, 'sum': 264424.0}, 'EL06_pos_2087': {'bp': 66020.0, 'sum': 232031.0}, 'EL23_pos_2285': {'bp': 65670.0, 'sum': 199366.0}, 'EL09_pos_2350': {'bp': 65656.0, 'sum': 204330.0}, 'EL16_pos_1769': {'bp': 64843.0, 'sum': 175171.0}, 'EL20_pos_2327': {'bp': 63941.0, 'sum': 207653.0}, 'EL21_pos_1766': {'bp': 63922.0, 'sum': 189399.0}, 'EL18_pos_1901': {'bp': 62702.0, 'sum': 194280.0}, 'EL17_pos_2320': {'bp': 62205.0, 'sum': 236896.0}, 'EL15_pos_2315': {'bp': 62158.0, 'sum': 205286.0}, 'EL16_pos_2303': {'bp': 61775.0, 'sum': 206202.0}, 'EL07_pos_2345': {'bp': 61565.0, 'sum': 216817.0}, 'Blanc3-pos_2068': {'bp': 60681.0, 'sum': 200514.0}, 'EL09_pos_1757': {'bp': 57175.0, 'sum': 149806.0}, 'Blanc3-pos_2267': {'bp': 57063.0, 'sum': 173633.0}, 'Blanc2-pos_1858': {'bp': 53877.0, 'sum': 197246.0}, 'Blanc3-pos_1817': {'bp': 53589.0, 'sum': 161627.0}, 'Blanc3-pos_2446': {'bp': 52135.0, 'sum': 134250.0}, 'Blanc2-pos_2578': {'bp': 50903.0, 'sum': 131380.0}, 'Blanc3-pos_2531': {'bp': 49771.0, 'sum': 121682.0}}
COMMENT: RETENTION_TIME_STDEV 0.439
COMMENT: PRECURSOR_M/Z_RAW 256.263444
COMMENT: PRECURSOR_M/Z_STDEV 0.000127
COMMENT: PRECURSOR_IN_MS1 mz 256.263383; int 30.314; delta(ppm) 1.220057
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.368; C16H33NO; [M+H]+; delta(ppm) -0.368258
COMMENT: PROPOSED_MF MS-FINDER 3.015; C16H33NO; [M+H]+; delta(ppm) -0.367255
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.085; C16H33NO; [M+H]+; delta(ppm) -0.367255
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C16H33NO; [M+H]+; delta(ppm) -0.367255
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.475; C16H33NO; [M+H]+; delta(ppm) -0.367255
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.067; C14H31N4; [M+H]+; delta(ppm) 4.872158
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H33NO; [M+H]+; delta(ppm) -0.367255
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 6.000; HSEMFIZWXHQJAE-UHFFFAOYSA-N; C16H33NO; Spectral Match to Palmitamide from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; LOTNCCWXPMLJSC-UHFFFAOYSA-N; C16H33NO; amylamine-C11:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.747; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)C)CCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.634; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.150; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; Palmitic amide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.734; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; Palmitic amide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.974; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.839; CWNSVVHTTQBGQB-UHFFFAOYSA-N; [M+H]+; N,N-diethyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.666; ZRIILUSQBDFVNY-UHFFFAOYSA-N; [M+H]+; 4-dodecylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.620; FQXSTGKJHBFSIQ-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.190; TWEPVARUEREPAN-UHFFFAOYSA-N; [M+H]+; 2-propyl-N-(2-propylpentyl)pentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.186; NTHVNXBUGUHNAH-UHFFFAOYSA-N; [M+H]+; N-butyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.175; XRGQSRGEPOBQIF-UHFFFAOYSA-N; [M+H]+; N,N-dipropyldecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; YJJHHUIJWCCSFA-UHFFFAOYSA-N; [M+H]+; N,N-dibutyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -10.455; HSEMFIZWXHQJAE; [M+H]+; Amide 16
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -69.584; NTHVNXBUGUHNAH; [M+H]+; Lauramide, N-butyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -76.314; KJXSXHGTHSJJMJ; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.551; CWNSVVHTTQBGQB; [M+H]+; Diethyllauramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.856; IRACWGPKDYUZEC; [M+H]+; N,N-Dibutyloctanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.262; FQXSTGKJHBFSIQ; [M+H]+; Dimethyl myristamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.183; TWEPVARUEREPAN; [M+H]+; 2-propyl-n-(2-propylpentyl)pentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.828; OVFJYDPLMRSSML; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -184.673; YJJHHUIJWCCSFA; [M+H]+; N,N-Dibutyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.767; ZRIILUSQBDFVNY; [M+H]+; Dodecyl morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.784; HSEMFIZWXHQJAE; [M+H]+; Amide 16
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -286.055; HSEMFIZWXHQJAE; [M+H]+; Palmitamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -292.390; IRACWGPKDYUZEC; [M+H]+; N,N-Dibutyloctanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -294.544; TWEPVARUEREPAN; [M+H]+; Pentanamide, 2-propyl-N-(2-propylpentyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -294.657; ZRIILUSQBDFVNY; [M+H]+; 4-Dodecylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -299.478; KJXSXHGTHSJJMJ; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -305.049; FQXSTGKJHBFSIQ; [M+H]+; Dimethyl(tetradecanoyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -311.804; YJJHHUIJWCCSFA; [M+H]+; Valeramide, N,N-dibutyl-2-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -311.865; OIJPFLBLDNXHOL; [M+H]+; 14-Methylpentadecanimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -316.151; OVFJYDPLMRSSML; [M+H]+; (3R)-3-pentadecyloxaziridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -316.583; NTHVNXBUGUHNAH; [M+H]+; N-butyldodecanimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.162; HSEMFIZWXHQJAE; [M+H]+; Palmitamide
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Palmitic amide, HSEMFIZWXHQJAE-UHFFFAOYSA-N; Matching to 6 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0012273;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C16H33NO
CH$EXACT_MASS: 255.256215
CH$SMILES: CCCCCCCCCCCCCCCC(=O)N
CH$IUPAC: InChI=1S/C16H33NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H2,17,18)
CH$LINK: CHEBI CHEBI:74475
CH$LINK: HMDB HMDB0012273
CH$NAME: Palmitic amide
CH$NAME: Palmitic amide
CH$NAME: hexadecanamide
CH$LINK: INCHIKEY HSEMFIZWXHQJAE-UHFFFAOYSA-N
CH$LINK: LIPIDMAPS LMFA08010009
CH$LINK: PUBCHEM CID:69421
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.483
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 256.263397
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-6090000000-b640c75b251855d62d39
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544806 68.1175 55.055188 0.6357 15.43 0.5846 25 f{C4H7}/4.61ppm,p-C12H27N1O1
  57.0701439 244.1380 57.070860 0.7710 40.08 0.3895 27 f{C4H9}/4.68ppm,p-C12H25N1O1
  67.0544296 39.1261 67.055171 1.1781 6.99 0.3070 19 f{C5H7}/3.03ppm,p-C11H27N1O1
  69.0699844 71.7032 69.070727 1.1438 14.89 0.5187 27 f{C5H9}/1.56ppm,p-C11H25N1O1
  71.0856652 71.4891 71.086408 0.9285 17.89 0.2200 25 f{C5H11}/1.95ppm,p-C11H23N1O1
  74.0601545 39.6436 74.060896 1.3638 10.59 0.1526 19 f{C3H8N1O1}/1.54ppm,p-C13H26
  80.9450592 41.7832 80.945786 1.2231 13.07 0.6105 20 ?
  81.0699501 55.1708 81.070677 1.0361 10.18 0.2000 20 f{C6H9}/0.91ppm,p-C10H25N1O1
  83.0856154 49.3378 83.086335 1.0712 15.49 0.0403 21 f{C6H11}/1.07ppm,p-C10H23N1O1
  88.0757312 121.6291 88.076428 0.8856 25.90 0.2192 25 f{C4H10N1O1}/0.46ppm,p-C12H24
  95.0854155 44.1968 95.086068 1.1148 10.49 0.4018 19 f{C7H11}/-1.17ppm,p-C9H23N1O1
  102.0913599 69.6064 102.091953 1.0971 14.73 0.3502 27 f{C5H12N1O1}/0.19ppm,p-C11H22
  254.9103178 176.8230 254.910690 1.1926 69.56 -0.0234 21 ?
  256.2634634 999.0000 256.263837 0.3044 0.00 1.0000 27 f{C16H34N1O1}/-0.11ppm,p
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  55.054481 68.12 68
  57.070144 244.14 244
  67.054430 39.13 39
  69.069984 71.70 71
  71.085665 71.49 71
  74.060154 39.64 39
  80.945059 41.78 41
  81.069950 55.17 55
  83.085615 49.34 49
  88.075731 121.63 121
  95.085415 44.20 44
  102.091360 69.61 69
  254.910318 176.82 176
  256.263463 999.00 999
//
